Laboratory diagnostics of connective tissue diseases and vasculitides;Labordiagnostik bei Kollagenosen und Vaskulitiden

Aktuelle Rheumatologie

Volumn 39, Issue 1, 2014, Pages 49-57

  Mierau, R ^a   Csernok, E ^b  

^a Rheumaklinik   (Germany)

^b Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

ANCA; antinuclear antibodies; autoantibodies; connective tissue disease; vasculitis

Indexed keywords

EID: 84894285436     PISSN: 0341051X     EISSN: 14389940     Source Type: Journal    
DOI: 10.1055/s-0033-1358737     Document Type: Article

References (53)

1. Sack U., Conrad K., Csernok E. et al. Autoantikörpernachweis mittels indirekter Immunfluoreszenz an HEp-2-Zellen. Dtsch Med Wochenschr: 2009; 134 1278 1282
2. Meroni P. L., Schur P. H. ANA screening: an old test with new recommendations. Ann Rheum Dis: 2010; 69 1420 1422
3. Nossent H., Rekvig O. P., Limburg P. C. et al. Antinuclear antibody screening in this new millennium: farewell to the microscope? Scand J Rheumatol: 2001; 30 123 128
4. Maguire G. A., Ginawi A., Lee J. et al. Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence. Rheumatology (Oxford): 2009; 48 1013 1014
5. Fritzler M. J. The antinuclear antibody test: Last or lasting gasp? Arthritis Rheum: 2011; 63 19 22
6. Mariz H. A., Sato E. I., Barbosa S. H. et al. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum: 2011; 63 191 200
7. Mahler M., Parker T., Peebles C. L. et al. Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases. J Rheumatol: 2012; 39 2104 2110
8. Voigt J., Krause C., Rohwäder E. et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol: 2012; 2012 651058
9. Willitzki A., Hiemann R., Peters V. et al. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol: 2012; 2012 284740
10. Tan E. M., Cohen A. S., Fries J. F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum: 1982; 25 1271 1277 (Pubitemid 13221242)
11. Hochberg M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum: 1997; 40 1725
12. Petri M., Orbai A. M., Alarcon G. S. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum: 2012; 64 2677 2686
13. Font J., Cervera R., Ramos-Casals M. et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum: 2004; 33 217 230 (Pubitemid 38280821)
14. Hoffman IE A., Peene I., Meheus L. et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis: 2004; 63 1155 1158 (Pubitemid 39120371)
15. Buyon J. P. Autoantibodies reactive with Ro(SSA) and La(SSB) and pregnancy. J Rheumatol: 1997; 24 12 16 (Pubitemid 27395883)
16. Arbuckle M. R., McClain M. T., Rubertone M. V. et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med: 2003; 349 1526 1533 (Pubitemid 37255038)
17. Heinlen L. D., Ritterhouse L. L., McClain M. T. et al. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med: 2010; 88 719 727
18. Smeenk R., Brinkman K., van den Brink H. et al. Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin Rheumatol: 1990; 9 100 110 (Pubitemid 20338111)
19. Vitali C., Bombardieri S., Jonsson R. et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis: 2002; 61 554 558 (Pubitemid 34539104)
20. Yoshimi R., Ueda A., Ozato K. et al. Clinical and pathological roles of Ro/SSA autoantibody system. Clin Dev Immunol: 2012; 2012 606195
21. Witte T. Pathogenese und Diagnostik des Sjögren-Syndroms. Z Rheumatol: 2010; 69 50 56
22. Mierau R., Moinzadeh P., Riemekasten G. et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features. Arthritis Res Ther: 2011; 13 R172
23. Masi A. T., Rodnan G. P., Medsger T. A. et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum: 1980; 23 581 590 (Pubitemid 10101764)
24. LeRoy E. C., Medsger T. A. Criteria for the classification of early Systemic Sclerosis. J Rheumatol: 2001; 28 1573 1576 (Pubitemid 32660630)
25. Fransen J., Johnson S. R., van den Hoogen FH J. et al. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res: 2012; 64 351 357
26. Nihtyanova S. I., Denton C. P. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol: 2010; 6 112 116
27. Dick T., Mierau R., Bartz-Bazzanella P. et al. Coexistence of anti-topoisomerase 1 and anti-centromere antibodies in patients with systemic sclerosis. Ann Rheum Dis: 2002; 61 121 127 (Pubitemid 34098426)
28. Steen V. D. The many faces of scleroderma. Rheum Dis Clin North Am: 2008; 34 1 15 (Pubitemid 351329460)
29. Mierau R., Genth E. Sklerodermie-assoziierte Autoantikörper - klinische und diagnostische Relevanz. Z Rheumatol: 2006; 65 279 284 (Pubitemid 44124537)
30. Svegliati Baroni S., Santillo M., Bevilacqua F. et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med: 2006; 354 2667 2676
31. Dragun D., Distler J. H., Riemekasten G. et al. Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: What functional autoimmunity could learn from receptor biology. Arthritis Rheum: 2009; 60 907 911
32. Riemekasten G., Philippe A., Nather M. et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis: 2011; 70 530 536
33. Bohan A., Peter J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med: 1975; 292 344 347
34. Targoff I. N. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am: 2002; 28 859 890 (Pubitemid 36008556)
35. Gunawardena H., Betteridge Z. E., McHugh N. J. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford): 2009; 48 607 612
36. Trallero-Araguas E., Rodrigo-Pendas J. A., Selva-O'Callaghan A. et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis. Arthritis Rheum: 2012; 64 523 532
37. Mammen A. L., Chung T., Christopher-Stine L. et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum: 2011; 63 713 721
38. Cappelli S., Bellando-Randone S., Martinovic D. et al. To be or not to be, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum: 2012; 41 589 598
39. Love L. A., Leff R. L., Fraser D. D. et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine: 1991; 70 360 374
40. Fries J. F., Hunder G. G., Bloch D. A. et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum: 1990; 33 1135 1136 (Pubitemid 20273299)
41. Jennette J. C., Falk R. J., Andrassy K. et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum: 1994; 37 187 192 (Pubitemid 24065492)
42. Jennette J. C., Falk R. J., Bacon P. A. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum: 2013; 65 1 11
43. Lyons P. A., Rayner T. F., Trivedi S. et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med: 2012; 367 214 223
44. Davies D. J., Moran J. E., Niall J. F. et al. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Brit Med J: 1982; 285 606 (Pubitemid 12042688)
45. van der Woude F. J., Rasmussen N., Lobatto S. et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet: 1985; 1 425 429 (Pubitemid 15173133)
46. Csernok E., Lamprecht P., Gross W. L. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol: 2006; 2 174 175
47. Savige J., Gillis D., Benson E. et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol: 1999; 111 507 513 (Pubitemid 29153147)
48. Holle J. U., Herrmann K., Gross W. L. et al. Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides. Clin Exp Rheumatol: 2012; 30 S66 S69
49. Arnold D. F., Timms A., Luqmani R. et al. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients. J Clin Pathol: 2010; 63 678 680
50. Tomasson G., Grayson P. C., Mahr A. D. et al. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis - a meta-analysis. Rheumatology (Oxford): 2012; 51 100 109
51. Holle J. U., Csernok E., Gross W. L. Non-ANCA-associated vasculitides. In: Shoenfeld Y., Meroni P. L. eds. The General Practice Guide to Autoimmune Diseases. Lengerich Papst Science Publishers: 2012; 103 116
52. Bosch X., Lopez-Soto A., Mirapeix E. et al. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med: 1994; 118 517 522 (Pubitemid 24176829)
53. Ferri C., Mascia M. T. Cryoglobulinemic vasculitis. Curr Opin Rheumatol: 2006; 18 54 63 (Pubitemid 43740406)